Independent Franchise Partners LLP Has $109.21 Million Stock Position in Ryan Specialty Holdings Inc. $RYAN

Key Points

• Independent Franchise Partners LLP increased its Ryan Specialty stake by 24.4% in the fourth quarter, ending with 2.12 million shares worth about $109.2 million. The position now represents 0.80% of Ryan Specialty and is the fund’s 25th largest holding.
• Ryan Specialty reported solid quarterly results, with EPS of $0.47 beating estimates and revenue of $795.23 million topping forecasts. Revenue rose 15.2% year over year, and the company also authorized a $300 million share repurchase program.
• Several insiders bought shares recently, including EVP Mark Stephen Katz and Director John W. Rogers, Jr., while analysts remain mixed overall. The stock currently has an average Hold rating and an average price target of $47.12.

Independent Franchise Partners LLP lifted its stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 24.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,115,313 shares of the company's stock after purchasing an additional 415,560 shares during the period. Ryan Specialty accounts for 0.7% of Independent Franchise Partners LLP's holdings, making the stock its 25th biggest position. Independent Franchise Partners LLP owned about 0.80% of Ryan Specialty worth $109,214,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Los Angeles Capital Management LLC bought a new stake in shares of Ryan Specialty during the 4th quarter worth approximately $25,000. Advisory Services Network LLC bought a new stake in shares of Ryan Specialty during the 3rd quarter worth approximately $28,000. SBI Securities Co. Ltd. raised its stake in shares of Ryan Specialty by 6,322.2% during the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company's stock worth $30,000 after purchasing an additional 569 shares in the last quarter. Fifth Third Bancorp raised its stake in shares of Ryan Specialty by 65.4% during the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company's stock worth $34,000 after purchasing an additional 242 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Ryan Specialty by 173.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $37,000 after purchasing an additional 450 shares in the last quarter. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Stock Down 0.5%

RYAN stock opened at $35.25 on Thursday. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $9.29 billion, a price-to-earnings ratio of 45.77, a PEG ratio of 0.85 and a beta of 0.64. The business's fifty day moving average price is $33.72 and its two-hundred day moving average price is $41.24. Ryan Specialty Holdings Inc. has a fifty-two week low of $29.28 and a fifty-two week high of $69.49.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $795.23 million for the quarter, compared to analysts' expectations of $781.44 million. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The company's quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.39 EPS. On average, equities analysts anticipate that Ryan Specialty Holdings Inc. will post 2.05 earnings per share for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, May 26th. Shareholders of record on Tuesday, May 12th were given a dividend of $0.13 per share. The ex-dividend date was Tuesday, May 12th. This represents a $0.52 annualized dividend and a yield of 1.5%. Ryan Specialty's dividend payout ratio (DPR) is presently 67.53%.

Ryan Specialty declared that its board has authorized a stock repurchase program on Tuesday, May 26th that permits the company to buyback $300.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 3.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Analysts Set New Price Targets

RYAN has been the topic of a number of analyst reports. JPMorgan Chase & Co. dropped their price objective on Ryan Specialty from $49.00 to $43.00 and set an "underweight" rating on the stock in a research note on Thursday, April 9th. Weiss Ratings reiterated a "sell (d+)" rating on shares of Ryan Specialty in a research note on Monday, May 4th. Morgan Stanley dropped their price objective on Ryan Specialty from $45.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, May 21st. Barclays dropped their price objective on Ryan Specialty from $41.00 to $39.00 and set an "overweight" rating on the stock in a research note on Friday, May 1st. Finally, Royal Bank Of Canada initiated coverage on Ryan Specialty in a research note on Tuesday, March 17th. They set an "outperform" rating and a $45.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $47.12.

Insiders Place Their Bets

In other news, EVP Mark Stephen Katz acquired 3,215 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average price of $31.07 per share, for a total transaction of $99,890.05. Following the transaction, the executive vice president directly owned 4,332 shares of the company's stock, valued at approximately $134,595.24. This represents a 287.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director John W. Rogers, Jr. acquired 7,500 shares of the stock in a transaction on Wednesday, June 10th. The shares were purchased at an average price of $35.16 per share, for a total transaction of $263,700.00. Following the transaction, the director directly owned 117,933 shares in the company, valued at approximately $4,146,524.28. This trade represents a 6.79% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 130,715 shares of company stock worth $4,263,590 in the last 90 days. Company insiders own 52.03% of the company's stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc NYSE: RYAN is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.

Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.